drugset / Trial / NCT06085352

Evaluate the TetraLens, a Tetracaine Releasing Therapeutic Bandage Contact Lens in Patients Undergoing PRK Procedure

NCT06085352

Phase 0 Completed 10 enrolled Vance Thompson Vision
RandomizedCrossoverSingle-blindTreatment

Summary

The goal of this clinical trial is to determine the safety, efficacy, and comfort of the investigational TetraLens bandage contact lens in patients who have undergone photorefractive keratectomy (PRK). The main question\[s\] it aims to answer are: * Understand benefit of managing pain following the surgical procedure * Understand the safety of the Tetralens Participants will be asked to wear theTetraLens BCL in one eye for 6 days post-operatively and: document the daily quantity of oral analgesics needed and report ocular pain and contact lens comfort. Researchers will compare the study lens in one eye to a control lens in the contralateral (other eye)

Timeline

Start
2023-06-26
Primary completion
2023-12-31
Completion
2024-01-25

Drugs

EvaluationDrugModalityDoseRoute
Subject tetracaine Other / unclassified Topical

Indications

No indication recorded.